Hill-Rom Holdings Inc (HRC) Holdings Boosted by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP boosted its holdings in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 1.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 867,924 shares of the medical technology company’s stock after buying an additional 12,219 shares during the quarter. Westfield Capital Management Co. LP owned approximately 1.32% of Hill-Rom worth $64,226,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Teacher Retirement System of Texas increased its position in Hill-Rom by 0.3% during the second quarter. Teacher Retirement System of Texas now owns 5,194 shares of the medical technology company’s stock worth $413,000 after buying an additional 14 shares during the last quarter. Stifel Financial Corp increased its position in Hill-Rom by 0.5% during the second quarter. Stifel Financial Corp now owns 4,379 shares of the medical technology company’s stock worth $349,000 after buying an additional 23 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Hill-Rom by 0.5% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,734 shares of the medical technology company’s stock worth $695,000 after buying an additional 46 shares during the last quarter. Utah Retirement Systems increased its position in Hill-Rom by 0.8% during the second quarter. Utah Retirement Systems now owns 12,013 shares of the medical technology company’s stock worth $956,000 after buying an additional 100 shares during the last quarter. Finally, IFP Advisors Inc increased its position in Hill-Rom by 3.0% during the second quarter. IFP Advisors Inc now owns 4,607 shares of the medical technology company’s stock worth $367,000 after buying an additional 135 shares during the last quarter. 82.30% of the stock is currently owned by hedge funds and other institutional investors.

Hill-Rom Holdings Inc (NYSE HRC) opened at $84.22 on Friday. Hill-Rom Holdings Inc has a 12-month low of $52.94 and a 12-month high of $85.25. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.77 and a quick ratio of 1.34. The company has a market capitalization of $5,543.44, a P/E ratio of 21.82, a PEG ratio of 1.79 and a beta of 1.19.

Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.27 by $0.05. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $731.10 million. During the same quarter in the prior year, the business earned $1.18 earnings per share. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. sell-side analysts expect that Hill-Rom Holdings Inc will post 4.26 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, December 14th. Hill-Rom’s dividend payout ratio (DPR) is currently 36.18%.

HRC has been the topic of several research reports. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a research report on Friday, October 27th. KeyCorp reaffirmed a “buy” rating and issued a $82.00 target price on shares of Hill-Rom in a research report on Tuesday, October 17th. Stifel Nicolaus upped their target price on Hill-Rom from $84.00 to $85.00 and gave the company a “buy” rating in a research report on Monday, November 6th. Needham & Company LLC decreased their target price on Hill-Rom from $93.00 to $90.00 and set a “buy” rating on the stock in a research report on Monday, November 6th. Finally, ValuEngine raised Hill-Rom from a “hold” rating to a “buy” rating in a research report on Thursday, November 16th. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Hill-Rom has a consensus rating of “Buy” and a consensus target price of $89.57.

In related news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.com-unik.info/2017/12/03/hill-rom-holdings-inc-hrc-holdings-boosted-by-westfield-capital-management-co-lp.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit